University of Victoria - Genome BC Proteomics Centre, Victoria, British Columbia V8Z 7X8, Canada.
University of Victoria, Victoria, British Columbia V8P 5C2, Canada.
J Proteome Res. 2021 Apr 2;20(4):2105-2115. doi: 10.1021/acs.jproteome.0c00961. Epub 2021 Mar 8.
Precise multiplexed quantification of proteins in biological samples can be achieved by targeted proteomics using multiple or parallel reaction monitoring (MRM/PRM). Combined with internal standards, the method achieves very good repeatability and reproducibility enabling excellent protein quantification and allowing longitudinal and cohort studies. A laborious part of performing such experiments lies in the preparation steps dedicated to the development and validation of individual protein assays. Several public repositories host information on targeted proteomics assays, including NCI's Clinical Proteomic Tumor Analysis Consortium assay portals, PeptideAtlas SRM Experiment Library, SRMAtlas, PanoramaWeb, and PeptideTracker, with all offering varying levels of details. We introduced MRMAssayDB in 2018 as an integrated resource for targeted proteomics assays. The Web-based application maps and links the assays from the repositories, includes comprehensive up-to-date protein and sequence annotations, and provides multiple visualization options on the peptide and protein level. We have extended MRMAssayDB with more assays and extensive annotations. Currently it contains >828 000 assays covering >51 000 proteins from 94 organisms, of which >17 000 proteins are present in >2400 biological pathways, and >48 000 mapping to >21 000 Gene Ontology terms. This is an increase of about four times the number of assays since introduction. We have expanded annotations of interaction, biological pathways, and disease associations. A newly added visualization module for coupled molecular structural annotation browsing allows the user to interactively examine peptide sequence and any known PTMs and disease mutations, and map all to available protein 3D structures. Because of its integrative approach, MRMAssayDB enables a holistic view of suitable proteotypic peptides and commonly used transitions in empirical data. Availability: http://mrmassaydb.proteincentre.com.
通过使用多重或平行反应监测 (MRM/PRM) 的靶向蛋白质组学可以实现对生物样品中蛋白质的精确定量。该方法结合内标,可实现非常好的重复性和重现性,从而实现出色的蛋白质定量,并允许进行纵向和队列研究。执行此类实验的一个繁琐部分在于专门用于开发和验证单个蛋白质测定的准备步骤。有几个公共存储库可提供靶向蛋白质组学测定的信息,包括 NCI 的临床蛋白质组肿瘤分析联盟测定门户、PeptideAtlas SRM 实验库、SRMAtlas、PanoramaWeb 和 PeptideTracker,它们都提供不同程度的详细信息。我们在 2018 年引入了 MRMAssayDB,作为靶向蛋白质组学测定的综合资源。基于 Web 的应用程序对存储库中的测定进行映射和链接,包括全面的最新蛋白质和序列注释,并提供肽和蛋白质水平的多种可视化选项。我们已经扩展了 MRMAssayDB 以包含更多的测定和广泛的注释。目前,它包含超过 828000 个测定,涵盖来自 94 个生物体的超过 51000 种蛋白质,其中超过 17000 种蛋白质存在于 2400 多种生物途径中,超过 48000 种蛋白质映射到 21000 多个基因本体术语。这是自推出以来测定数量增加了约四倍。我们扩展了相互作用、生物途径和疾病关联的注释。新添加的用于耦合分子结构注释浏览的可视化模块允许用户交互式地检查肽序列和任何已知的 PTMs 和疾病突变,并将所有内容映射到可用的蛋白质 3D 结构。由于其集成方法,MRMAssayDB 可以全面了解经验数据中合适的蛋白质肽和常用跃迁。可用性:http://mrmassaydb.proteincentre.com。